KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.94% | 8.01% | 3.85% | 9.86% | 8.74% |
| Total Depreciation and Amortization | 22.39% | 27.69% | -3.26% | -10.62% | -14.52% |
| Total Amortization of Deferred Charges | -153.45% | -38.62% | -21.47% | -9.22% | -0.40% |
| Total Other Non-Cash Items | -90.85% | -41.63% | 149.99% | 162.52% | 146.04% |
| Change in Net Operating Assets | -210.34% | 37.73% | -82.62% | -142.04% | -120.00% |
| Cash from Operations | -8.88% | 1.38% | 15.72% | 5.93% | -5.21% |
| Capital Expenditure | 92.79% | 42.47% | 48.07% | 62.14% | 65.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.79% | 42.47% | -101.81% | 41.62% | 51.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -346.09% | -42,205.56% | -- | -- | 49.55% |
| Issuance of Common Stock | -65.47% | -24.52% | -25.09% | 619.65% | 43.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -78.92% | -100.00% | -100.00% | -100.00% | 334.50% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.84% | -0.84% | -0.84% | -0.84% | 94.17% |
| Cash from Financing | -138.89% | -84.43% | -85.37% | 51.20% | 251.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15,353.15% | -309.65% | -550.41% | 59.20% | 101.44% |